BioSpace News Archive

Business

New Medicare choice for Southeast Alabama

VIVA MEDICARE is expanding into Houston, Henry, Geneva and Dale counties for 2019.

October 23, 2018
·
3 min read
Drug Development

OrthoTrophix Presents Knee Cartilage Structure Modification Data of TPX-100 at American College of Rheumatology Annual Meeting

OrthoTrophix, a privately held biopharmaceutical company, announced today that the company and its collaborators presented the Phase 2 clinical study data of TPX-100 demonstrating structural improvement of knee cartilage associated with robust knee function improvement in knee osteoarthritis (OA) patients at the American College of Rheumatology (ACR/ARHP) Annual Meeting in Chicago, IL

October 23, 2018
·
3 min read
Pharm Country

Medidata Sets Major New Corporate Social Responsibility (CSR) Commitments

Company expands CSR pledges, including participation in the UN Global Compact and the CEO Action on Diversity, and outlines new program goals for the next five years

October 23, 2018
·
3 min read
Deals

Proteostasis Therapeutics Prices Public Offering of 11,000,000 Shares of Its Common Stock

Proteostasis Therapeutics, Inc. announced today that it has priced an underwritten public offering of 11,000,000 shares of its common stock at a price to the public of $6.75 per share.

October 23, 2018
·
5 min read
FDA

CStone Receives US FDA IND Approval for Recombinant PD-1 mAb CS1003

CStone Pharmaceuticals today announced that the United States Food and Drug Administration (FDA) has recently granted approval to the company’s Investigational New Drug (IND) application for the independently developed recombinant humanized anti-programmed death-1 (PD-1) monoclonal antibody (mAb) CS1003.

October 23, 2018
·
3 min read